參考文獻 |
Bibliography
1. Pellati, D., et al., Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol, 2008. 140(1): p. 3-11.
2. Heinonen, P.K. and M. Leinonen, Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole. Arch Gynecol Obstet, 2003. 268(4): p. 284-8.
3. Doxanakis, A., et al., Missing pelvic inflammatory disease? Substantial differences in the rate at which doctors diagnose PID. Sex Transm Infect, 2008. 84(7): p. 518-23.
4. Ness, R.B., et al., A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol, 2005. 162(6): p. 585-90.
5. Heinonen, P.K. and A. Miettinen, Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol, 1994. 57(2): p. 85-9.
6. Chen, C.S. and H. Zhu, Protein microarrays. Biotechniques, 2006. 40(4): p. 423, 425, 427 passim.
7. Chen, C.S., et al., A proteome chip approach reveals new DNA damage recognition activities in Escherichia coli. Nat Methods, 2008. 5(1): p. 69-74.
8. Chen, C.S., A.J. Baeumner, and R.A. Durst, Protein G-liposomal nanovesicles as universal reagents for immunoassays. Talanta, 2005. 67(1): p. 205-11.
9. Chen, C.S. and R.A. Durst, Simultaneous detection of Escherichia coli O157:H7, Salmonella spp. and Listeria monocytogenes with an array-based immunosorbent assay using universal protein G-liposomal nanovesicles. Talanta, 2006. 69(1): p. 232-8.
10. Park, S. and R.A. Durst, Immunoliposome sandwich assay for the detection of Escherichia coli O157:H7. Anal Biochem, 2000. 280(1): p. 151-8.
11. Ho, J.A. and R.A. Durst, Detection of fumonisin B1: comparison of flow-injection liposome immunoanalysis with high-performance liquid chromatography. Anal Biochem, 2003. 312(1): p. 7-13.
12. Rucker, V.C., K.L. Havenstrite, and A.E. Herr, Antibody microarrays for native toxin detection. Anal Biochem, 2005. 339(2): p. 262-70.
13. Haab, B.B., Multiplexed protein analysis using antibody microarrays and label-based detection. Methods Mol Med, 2005. 114: p. 183-94.
14. Brown, H.L., et al., Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol, 2004. 12(1): p. 17-21.
15. Bravo, A.B., et al., Validation of an immunologic diagnostic kit for infectious vaginitis by Trichomonas vaginalis, Candida spp., and Gardnerella vaginalis. Diagn Microbiol Infect Dis, 2009. 63(3): p. 257-60.
16. Cauci, S., et al., Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis. Am J Obstet Gynecol, 1998. 178(3): p. 511-5.
17. Kaur, S., et al., Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis. Parasitol Res, 2008. 103(2): p. 305-12.
18. Brook, I., Microbiology and management of polymicrobial female genital tract infections in adolescents. J Pediatr Adolesc Gynecol, 2002. 15(4): p. 217-26.
19. Dodson, M.G., Optimum therapy for acute pelvic inflammatory disease. Drugs, 1990. 39(4): p. 511-22.
20. Cauci, S., et al., Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes. J Clin Microbiol, 2003. 41(1): p. 435-8.
21. Donders, G., Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv. 65(7): p. 462-73.
22. Field, E., et al., Evaluation of clinical management of gonorrhoea using enhanced surveillance in South East Queensland. Sex Health. 7(4): p. 448-52.
23. Shattock, R.M., et al., Detection of Chlamydia trachomatis in genital swabs: comparison of commercial and in house amplification methods with culture. Sex Transm Infect, 1998. 74(4): p. 289-93.
24. Sweet, R.L. and R.S. Gibbs, Infectious Diseases of the Female Genital Tract, Fifth Edition Edited by Richard L. Sweet and Ronald S. Gibbs Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Williams, 2009 . 5 ed. 2009, Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Williams. 469.
25. WHO, Sexually Transmitted and Other
Reproductive Tract Infections, in A guide to essential practice, R.H.a. Research, Editor. 2005. p. 40-49.
26. Vickerman, P., et al., Detection of gonococcal infection : pros and cons of a rapid test. Mol Diagn, 2005. 9(4): p. 175-9.
27. Unemo, M., et al., Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies. Sex Transm Infect, 2007. 83(1): p. 47-51.
28. Rao, G.G., et al., Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex Transm Infect, 2008. 84(2): p. 117-21.
29. Ryan, C.A., et al., Reproductive tract infections in primary healthcare, family planning, and dermatovenereology clinics: evaluation of syndromic management in Morocco. Sex Transm Infect, 1998. 74 Suppl 1: p. S95-105.
30. Benzaken, A.S., et al., Diagnosis of gonococcal infection in high risk women using a rapid test. Sex Transm Infect, 2006. 82 Suppl 5: p. v26-8.
31. Diallo, M.O., et al., Evaluation of simple diagnostic algorithms for Neisseria gonorrhoeae and Chlamydia trachomatis cervical infections in female sex workers in Abidjan, Cote d’’Ivoire. Sex Transm Infect, 1998. 74 Suppl 1: p. S106-11.
32. Wi, T., et al., Syndromic approach to detection of gonococcal and chlamydial infections among female sex workers in two Philippine cities. Sex Transm Infect, 1998. 74 Suppl 1: p. S118-22.
33. Monteiro, E.F., C.J. Lacey, and D. Merrick, The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases. Sex Transm Infect, 2005. 81(1): p. 41-6.
34. Romoren, M., et al., Chlamydia and gonorrhoea in pregnant Batswana women: time to discard the syndromic approach? BMC Infect Dis, 2007. 7: p. 27.
35. Myziuk, L., B. Romanowski, and M. Brown, Endocervical Gram stain smears and their usefulness in the diagnosis of Chlamydia trachomatis. Sex Transm Infect, 2001. 77(2): p. 103-6.
36. Schachter, J., et al., Enzyme immunoassay for diagnosis of gonorrhea. J Clin Microbiol, 1984. 19(1): p. 57-9.
37. Alary, M., et al., Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin. Sex Transm Infect, 2006. 82 Suppl 5: p. v29-32.
38. Hardwick, R., G. Gopal Rao, and H. Mallinson, Confirmation of BD ProbeTec Neisseria gonorrhoeae reactive samples by Gen-Probe APTIMA assays and culture. Sex Transm Infect, 2009. 85(1): p. 24-6.
39. Van Dyck, E., et al., Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol, 2001. 39(5): p. 1751-6.
40. Bignell, C., C.A. Ison, and E. Jungmann, Gonorrhoea. Sex Transm Infect, 2006. 82 Suppl 4: p. iv6-9.
41. Gopal Rao, G., et al., Can culture confirmation of gonococcal infection be improved in female subjects found to be positive by nucleic acid amplification tests in community clinics? Sex Transm Infect, 2009. 85(7): p. 531-3.
42. Lum, G., et al., A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR. Sex Transm Infect, 2005. 81(5): p. 400-2.
43. Ison, C., GC NAATs: is the time right? Sex Transm Infect, 2006. 82(6): p. 515.
44. Kellogg, J.A., Impact of variation in endocervical specimen collection and testing techniques on frequency of false-positive and false-negative Chlamydia detection results. Am J Clin Pathol, 1995. 104(5): p. 554-9.
45. Vickerman, P., et al., Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect, 2003. 79(5): p. 363-7.
46. CDC, 2010 Treatment Guidelines for Sexually Transmitted Diseases. Morb Mortal Wkly Rep. 2010;59:1-109.
, 2010. 2010(59): p. 1-109.
47. Suzuki, K., et al., Evaluation of a rapid antigen detection test for Neisseria gonorrhoeae in urine sediment for diagnosis of gonococcal urethritis in males. J Infect Chemother, 2004. 10(4): p. 208-11.
48. Ho, M.K., et al., Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting. Sex Transm Infect, 2009. 85(5): p. 322-5.
49. Verhelst, R., et al., Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol, 2005. 5: p. 61.
50. De Backer, E., et al., Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol, 2007. 7: p. 115.
51. Su, W.H., et al., Diagnosis of Chlamydia infection in women. Taiwan J Obstet Gynecol. 50(3): p. 261-7.
52. Timothy L. Clenney, S.K.J., Marion Owen, Vaginitis. CLINICS IN FAMILY PRACTICE, march, 2005. 7(1): p. 10.
53. Lan, P.T., et al., Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect, 2008. 84(2): p. 126-32.
54. Schneider, H., et al., Screening for sexually transmitted diseases in rural South African women. Sex Transm Infect, 1998. 74 Suppl 1: p. S147-52.
55. Christian, P., et al., Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women. Sex Transm Infect, 2005. 81(3): p. 254-8.
56. WHO, SDI is promoting the development and evaluation of diagnostics that are ASSURED. Sexually transmitted diseases Diagnostics Initiative, 2011. About SDI(Priorities): p. 1.
57. Huppert, J., E. Hesse, and C.A. Gaydos, What’’s the Point? How Point-of-Care STI Tests Can Impact Infected Patients. Point Care. 9(1): p. 36-46.
58. Raddi, M.S., A.F. Vidal, and D.M. Santana, Characteristics of gram-stained cervical smear from patients with Chlamydia trachomatis infection. Rev Latinoam Microbiol, 1993. 35(2): p. 159-61.
59. Landis, S.J., et al., Value of the gram-stained urethral smear in the management of men with urethritis. Sex Transm Dis, 1988. 15(2): p. 78-84.
60. Saxena, S.B. and D. Feriozi, An evaluation of urethral smear by Papanicolaou stain in men with urethritis. J Adolesc Health Care, 1988. 9(1): p. 76-81.
61. Knud-Hansen, C.R., et al., Surrogate methods to diagnose gonococcal and chlamydial cervicitis: comparison of leukocyte esterase dipstick, endocervical gram stain, and culture. Sex Transm Dis, 1991. 18(4): p. 211-6.
62. Nelson, H.D. and M. Helfand, Screening for chlamydial infection. Am J Prev Med, 2001. 20(3 Suppl): p. 95-107.
63. Watson, E.J., et al., The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol, 2002. 51(12): p. 1021-31.
64. Bandea, C.I., et al., Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women. J Clin Microbiol, 2009. 47(1): p. 215-6.
65. Yin, Y.P., et al., Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex Transm Infect, 2006. 82 Suppl 5: p. v33-7.
66. Rani, R., et al., Is there any role for rapid tests for Chlamydia trachomatis? Int J STD AIDS, 2002. 13(1): p. 22-4.
67. Mahilum-Tapay, L., et al., New point of care Chlamydia Rapid Test--bridging the gap between diagnosis and treatment: performance evaluation study. BMJ, 2007. 335(7631): p. 1190-4.
68. Masek, B.J., et al., Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol, 2009. 47(6): p. 1663-7.
69. Van Der Pol, B., et al., Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol, 2001. 39(3): p. 1008-16.
70. Nelson HD, S.S., Helfand M. , Screening for Chlamydial Infection [Internet]. in Systematic Evidence Reviews, No. 3, R. (MD), Editor. April, 2001, AHRQ Publication No. 01-S003: Prepared by the Oregon Health Sciences University Evidence-based Practice Center under Contract No 290-97-0018.
71. Uttamchandani, M., et al., Applications of microarrays in pathogen detection and biodefence. Trends Biotechnol, 2009. 27(1): p. 53-61.
72. Palmer, H.M., et al., Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex Transm Infect, 2008. 84(4): p. 280-4.
73. Su, W.H., et al., Are we satisfied with the tools for the diagnosis of gonococcal infection in females? J Chin Med Assoc. 74(10): p. 430-4.
|